Tag:
Adimab
Latest Headlines
Latest Headlines
Adimab adds Gilead pact to its growing roster of antibody deals
Gilead Sciences--in the news today with some stellar hep C data--has turned to Adimab to work on antibodies for two undisclosed targets.
Google contributes to $14M round for fast-growing Adimab
Fast-growing Adimab has added close to $14 million in venture cash to the bank as it hires on new staffers and preps for a move into a 21,500-square-foot lab in Lebanon, NH.
Adimab adds Novo, Biogen Idec to roster of antibody partners
The antibody developers at Adimab have added two more big names in biopharma to their roster of collaborators: Novo Nordisk and Biogen Idec. Each big developer turned to the Lebanon, NH-based biotech
Adimab inks deals with Lilly, Genentech and HGS
Lebanon, NH-based Adimab has added some noteworthy players to its long list of partners trying out its antibody development technology. The 2010 Fierce 15 company announced today that Eli Lilly,
With Novartis deal, Adimab expects profitability this year
Lebanon, NH-based Adimab has inked a research collaboration with Novartis , marking its fifth deal with a major pharma company in just over a year. The developer will use its discovery platform to
Google venture arm goes biotech in Adimab Series D
Armed with a plan to invest $100 million in the next year in the life sciences and technology, the newly-formed Google Ventures has made its first biotech investment, leading a Series D for the
Radius adds $15M to third venture round
Radius Health has ginned an additional $15 million for its Series C, bringing its total take to $82.5 million. All existing institutional investors participated in the financing, led by MPM Bio IV
